Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 12, 2026
Context: This filing serves as a cover document to furnish an attached "Intimation" (Exhibit 99.1) dated February 12, 2026, to the U.S. Securities and Exchange Commission. The registrant is a foreign private issuer incorporated in India.
Key Financial Metrics
The provided filing text does not contain specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed in this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. The document is a procedural submission referencing an attached intimation without detailing its financial or operational content.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. The content is limited to the cover page and signature block of the Form 6-K.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Intimation dated February 12, 2026) to determine the specific material event or announcement being reported.
- Verify if the intimation relates to regulatory approvals, litigation, executive changes, or financial results not detailed in the cover form.
- Confirm the filing status under Rule 12g3-2(b) (marked "No" in this document).